Alpha Cognition (ACOG) Cost of Revenue (2025 - 2026)

Alpha Cognition (ACOG) posted quarterly Cost of Revenue of $179334.0 for Q4 2025, up 10.17% quarter-over-quarter from $162777.0 in Q3 2025.

Alpha Cognition (ACOG) Cost of Revenue (2025 - 2026) Analysis & Trends

Alpha Cognition's Cost of Revenue history runs 1 years deep, the most recent figure standing at $179334.0 for Q4 2025.

In Q4 2025, Cost of Revenue changed N/A year-over-year to $179334.0; the TTM figure through Dec 2025 stood at $809631.0 (changed N/A YoY), while the FY2025 annual figure was $474006.0, changed N/A from the prior year.
Cost of Revenue for Q4 2025 stood at $179334.0, up from $162777.0 in the prior quarter.
The five-year high for Cost of Revenue was $440979.0 in Q2 2025, with the low at $26541.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	489.20 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	360.70 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	145.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	93.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	174.53 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	298.26 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	387.98 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	67.21 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Alpha Cognition	219.48 Mn	178.04 Mn	5.70 Mn	391,057.00

Download Data